Johnson & Johnson
NYSE: JNJ
$162.78
-$0.44 (-0.3%)
Closing Price on September 24, 2024
JNJ Articles
With the markets down so much today on the financial stock fallout after the Citi downgrade/concern and with oil stocks listing lower after the Exxon miss, we wanted to show a brief comparison of...
Published:
Last Updated:
"William O’Neill, dean of clinical affairs at University of Miami’sMiller School of Medicine, says stent-patient traffic is beginning topick up in South Florida. Still, restoring luster to the...
Published:
Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the company itself. Luckily for Amgen, much of the bad news may already be baked...
Published:
Last Updated:
Johnson & Johnson (JNJ) announced third-quarter sales of $15.0 billion, an increase of 12.7% as compared to the third quarter of 2006.Net earnings and diluted earnings per share for the third...
Published:
Medtronic (MDT) got the FDA to approve its new drug-coated stent called the Endeavor. The agency did have some concerns about whether the product has long-term risks or whether it is more effective...
Published:
Medtronic (MDT) has decided to get into the stent business, making the little mesh tubes that keep arteries open. It is a perverse selection because Boston Scientific (BSX) and Johnson & Johnson...
Published:
Stent sales for Boston Scientific (BSX) and Johnson & Johnson (JNJ) have taken a big drop since research began to emerge that the products could cause heart problems. There have been several...
Published:
According to Reuters, Intel (INTC) received antitrust charges from a branch of the South Korean government. Reuters writes that Campbell (CPB) is seeking over $1 billion for its Godiva chocolate...
Published:
ISIS Pharmaceuticals Inc. (NASDAQ:ISIS) is trading up pre-market on new that it entered a broad collaboration with Ortho-McNeil, a Johnson & Johnson (NYSE:JNJ) unit, for discovery, development...
Published:
Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels in...
Published:
Last Updated:
We are frequently asked about how certain basket picks perform compared to the overall market. It has been years since anyone has claimed their stocks should gain regardless of the market because...
Published:
If you ever heard the old saying "Be careful what you wish for, you may get it!" it sure seems like we are there. It also makes you wonder if it is time to go back into Defensive Stocks. The...
Published:
Last Updated:
According to Reuters, Countrywide (CFC) will eliminate 900 jobs. Reuters writes that Apple (AAPL) is looking for higher sales and Europe launch of the iPhone as part of the reason it cut prices on...
Published:
After reports last week that drug-coated stents posed little risk to heart patients, a new survey shows that "patients given drug-coated stents after an acute heart attack are nearly five times...
Published:
Last week was a light volume trading week, but the markets were open and they didn’t wait for the holiday crowd to come back. Here is a snippet of some of the major moves of the last week:...
Published:
Last Updated: